A 4-week, phase 2, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and pharmacokinetic profile of 1 and 5 mg Ph-797804 administered once daily in subjects with rheumatoid arthritis who are taking oral methotrexate

Trial Profile

A 4-week, phase 2, randomized, double-blind, placebo-controlled, parallel group study to evaluate the safety and pharmacokinetic profile of 1 and 5 mg Ph-797804 administered once daily in subjects with rheumatoid arthritis who are taking oral methotrexate

Completed
Phase of Trial: Phase II

Latest Information Update: 18 May 2011

At a glance

  • Drugs PH 797804 (Primary)
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Most Recent Events

    • 28 Apr 2011 Actual initiation date changed from Feb 2008 to Mar 2008 as reported by ClinicalTrials.gov.
    • 28 Apr 2011 Actual end date changed from Nov 2008 to Oct 2008 as reported by ClinicalTrials.gov.
    • 18 Nov 2008 Status changed from recruiting to completed, based on information from ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top